Hello, Guest
Login
Sign Up
 
 

Rocking Penny Stocks Issues a Report on Trending Stocks - CERP, CBAI, GNBT, SVEN

 
 
Repost This

Lakeland, FL -- (SBWIRE) -- 01/24/2013 -- Rocking Penny Stocks, an organization specializing in market analysis and news assessment, is dedicated to diligently striving to insure that our subscribers are better informed investors. At Rocking Penny Stocks, we focus on discovering Awesome Penny Stocks with substantial growth potential.

Cereplast, Inc. (PINK:CERP) opened its shares at the price of $0.03 for the day and its closing price was $0.0291 after gaining 17.34% for the day. The company traded with the total volume of 74.54 million shares, while its average trading volume remained 6.31 million shares. The beta of CERP stands at 0.81.

Have a look at the company’s graph:

During its last 5 trades, the stock jumped almost 104.93%. During the last one month it slipped -0.34%. Its year to date performance remained progressive 29.33%.

The 52-week price range of the stock remained $0.01 - $1.25, while during last trade its minimum price was $0.03 and it gained its highest price of $0.04.

Cereplast, Inc., a prominent manufacturer of proprietary biobased, sustainable and compostable bioplastics, reported a shareholder update and an outlook for 2013.

What was the Moving Force behind CERP's Bullish Run? Read This Research Report

Cord Blood America Inc. (OTC:CBAI) percentage change reduced -7.14% to close at $0.0026 with the total traded volume of 7.71 million shares, less than average volume of 9.60 million.

The Company’s year to date performance remained negative with the decline of -48%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -80.88%

Its beta value stands at -0.48 times and earnings per share was $ -0.02. The company has a total of 250 million outstanding shares and its total market capitalization is $649,998. The 52-week high price of the stock remained $0.05.

Why Should Investors Buy CBAI After the Recent Fall? Just Go Here and Find Out

Generex Biotechnology Corporation (OTC: GNBT) started its day-trading session with the price of $0.04 and closed at price of $0.0390 after scoring 8.33%.

An analysis from its graph:

Previous 5 days graph demonstrated a positive move of 16.77%. GNBT’s quarterly performance remained in the red with the percentage of -27.78, while its year to date performance showed that the stock advanced overall 56%. The beta of the GNBT stands at 1.60.

GNBT’s stocks traded with total volume of 7.47 million shares, while the average trading capacity remained 3.62 million shares.

Will GNBT Continue To Move Higher? Find Out Here

Superior Venture Corp (OTC:SVEN), during the previous trading session, the stock showed a negative movement of -12.04%.

Graph values of the stock demonstrate these trends:

Year to date performance of the stock remained negative with the decline -26.92%. SVEN traded with volume of 4.76 million shares, while its average trading ability remained 15.45 million shares.

Currently, the company has a market capitalization of $4.32 billion. The stock’s closing price was $0.0095, while it started its day-trade at $0.01. Its 52-week price range was $0.01 - $0.35.

Has SVEN Found The Bottom and is Now Ready To Move Up? Find Out Here

About Rocking Penny Stocks
At Rocking Penny Stocks, we focus on discovering stocks with substantial growth potential. We search for microcap stocks able to generate aggressive short and long term gains when driven by time sensitive news and events. Now you might be asking what it is that makes microcap stocks rise in value so quickly. It is almost always because of positive news announcements about the company. Get the hottest microcap stock alerts, news, and information right here! Join our free Penny Stock newsletter.

Disclaimer
The assembled information disseminated by rockingpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Rockingpennystocks.com does not expect that investors will buy and sell securities based on information assembled and presented in Rockingpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.